Cullinan Oncology, Inc.

NASDAQ:CGEM

17.23 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 0000000000-37.8480018.94300000000
Cost of Revenue 0.0770.0760.0770.080.0810.0720.0590.009000.0120.0130.013000000000
Gross Profit -0.077-0.076-0.077-0.08-0.081-0.072-0.059-0.00900-37.86-0.013-0.01318.94300000000
Gross Profit Ratio 0000000000100100000000
Reseach & Development Expenses 36.25930.64634.84833.82127.39152.09621.32119.6826.41124.53620.87812.6811.77812.41516.6299.91312.4964.1733.8025.2763.8553.855
General & Administrative Expenses 13.76812.34310.63710.98210.21410.6611.28710.08610.6958.12113.4685.6954.8265.15612.5441.5861.6261.3681.1771.4771.2141.214
Selling & Marketing Expenses -0.077-0.076-0.07700000000000000000.20.10.1
SG&A 13.69112.26710.5610.98210.21410.6611.28710.08610.6958.12113.4685.6954.8265.15612.5441.5861.6261.3681.1771.6771.3141.314
Other Expenses -0.072-0.044-0.1170.180.0690.1070.2980-0.24100.004-0.002-0.008-0.002-0.01200.00100000
Operating Expenses 49.9542.91345.40844.80337.60562.75632.60829.76637.10632.65734.34618.37516.60417.57129.17311.49914.1225.5414.9796.955.1715.171
Operating Income -50.027-42.989-45.485-45.243-37.605-62.756-32.608-29.766239.679-32.657-34.346-18.375-16.6041.372-29.173-11.499-14.122-5.541-4.979-6.953-5.169-5.169
Operating Income Ratio 00000000000.907000.07200000000
Total Other Income Expenses Net 7.9995.6495.8-0.260.0694.6153.6622.3530.4560.1970.004-0.002-0.008-0.002-0.0120.1850.0010.3780.2480.1040.1320.132
Income Before Tax -42.028-37.34-39.685-39.183-32.214-58.141-28.946-27.413240.135-32.46-34.205-18.259-16.4391.419-29.106-11.314-13.875-5.163-4.731-6.849-5.037-5.037
Income Before Tax Ratio 00000000000.904000.07500000000
Income Tax Expense 0-0.192-14.122-5.44-5.403-0.179-1.858-2.52366.07-19.5680.223-1.027-0.9761.4256.899-1.456-5.499-0.19-0.162-0.266-0.285-0.285
Net Income -42.028-37.148-23.803-39.183-32.214-57.962-27.088-24.89174.898-12.892-32.513-17.35-15.636-0.07-28.346-9.858-8.622-4.973-4.569-6.583-4.753-4.753
Net Income Ratio 00000000000.85900-0.00400000000
EPS -0.76-0.86-0.56-0.92-0.81-1.42-0.59-0.553.9-0.29-0.76-0.4-0.36-0.002-0.68-0.26-0.45-0.26-0.24-6.83-5.94-5.94
EPS Diluted -0.76-0.86-0.56-0.92-0.81-1.42-0.59-0.553.77-0.29-0.74-0.4-0.36-0.002-0.68-0.26-0.45-0.26-0.24-6.82-5.94-5.94
EBITDA -49.95-42.913-45.408-44.283-37.605-62.684-32.608-29.757-313.879-32.644-34.346-18.362-16.5911.372-29.158-11.484-14.106-5.525-4.962-6.937-5.151-5.151
EBITDA Ratio 00000000000.907000.07200000000